Skip to main content
Premium Trial:

Request an Annual Quote

Modell Foundation, Veritas Strike Deal to Test Thousands for Primary Immunodeficiency

NEW YORK – The Jeffrey Modell Foundation has struck an agreement with health and wellness testing company LetsGetChecked's genomics arm to test thousands of children worldwide for primary immunodeficiency disorders, the organizations announced Tuesday.

The Jeffrey Modell Foundation, a not-for-profit named for Jeffrey Modell, who passed away from complications of a primary immunodeficiency disorder at age 15, supports early diagnosis and treatment development for the condition. There are more than 300 primary immunodeficiency disorders, rare genetic conditions in which the immune system doesn't work correctly.

As part of the collaboration, more than 900 physician members who are part of the Jeffrey Modell Centers Network will be able to offer genomic sequencing services from Veritas, a company that LetsGetChecked acquired last year, to patients suspected of having a primary immunodeficiency to identify possible genetic mutations.

The goal is to test thousands of children and provide early diagnosis and treatment.

"The diagnostic journey for patients with a PI is long and can take them to numerous pediatric specialists before a specific genetic diagnosis and treatment may be offered," said Luis Izquierdo, chief medical officer at Veritas, in a statement.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.